The dos and don’ts of non-invasive prenatal testing

A new report from the Nuffield Council on Bioethics supports the use of a non-invasive prenatal testing (NIPT) technique recently approved for use as part of the NHS Fetal Anomaly Screening Programme in pregnancy, as well as setting out some concerns surrounding current commercial provision and potential future uses of testing.

Patient empowerment, prenatal testing and abortion

The rapidly expanding capacity to diagnose serious chromosomal defects via early, safe non-invasive prenatal testing (NIPT) is arguably one of the most exciting medical developments of recent years. Progress has been very fast in the years since the PHG Foundation published the first report to examine the potential health service implications of NIPT in 2009. That report outlined looked for...

NIPT for Down’s syndrome – what new evidence means for the UK

Non-invasive cell–free DNA prenatal testing (NIPT) is an exciting new development in antenatal care, since it offers the potential to reduce the need for invasive antenatal testing and the associated risk of miscarriage. Efforts to evaluate this test in the form of clinical research trials have been underway for some years. Whilst the technique has demonstrated good performance as a scr...

China approves non-invasive prenatal tests from BGI

China has issued the first regulatory approval for a non-invasive prenatal genetic testing product – to the Chinese Bejing Genomics Institute (BGI).

China imposes restrictive regulation of genetic testing

China’s Food and Drug Administration has acted to impose regulatory constraints on the provision of clinical genetic tests.

Will new technologies normalise sex selective abortion?

The Department of Health has launched an inquiry after the Telegraph newspaper reported evidence that doctors at abortion clinics in the UK were prepared to terminate pregnancies on the grounds of foetal sex.